Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Preview

Cluster news

Tuberkulosebakterien

How does resistance develop—and what can be done to preserve Antibiotic effectiveness?

Researchers at the FZB have defined the areas in which the development of resistance to two important tuberculosis drugs is favored.

 
Scientists in the lab

New insights into microbiome-mediated protection against pathogens

A specific intestinal bacterium produces sphingolipids, via an alternative metabolic pathway, that provide host protection against infection. 
 

 

 

Antibodies in Focus: New Research Training Group Established in Lübeck

The new Research Training Group GRK3095 will investigate the mechanisms by which antibodies trigger either protective or disease-causing responses in the skin, lungs, and gut.

 

 
portrait photo

ERC Advanced Grant: €2.5 Million in Research Funding for Alexander Scheffold

Immunologist from the Cluster of Excellence PMI receives prestigious European Research Council grant for work on regulatory T cells.